Related Experiment Video
Updated: Oct 5, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Ero1α-Dependent ERp44 Dissociation From RyR2 Contributes to Cardiac Arrhythmia
Shanna Hamilton1,2, Radmila Terentyeva1,2, Vladimir Bogdanov1,2
1Department of Physiology and Cell Biology (S.H., R.T., V.B., F.P., J.Y., X.A., A.E.B., J.P.D., S.G., D.T.), The Ohio State University.
Insights
Oxidative stress in cardiac disease increases RyR2 channel activity. Inhibiting Ero1α stabilizes the RyR2-ERp44 complex, reducing arrhythmias in hypertrophic hearts.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Oxidative Stress Research
Background:
- Oxidative stress in cardiac disease disrupts calcium (Ca2+) homeostasis, affecting sarcoplasmic reticulum (SR) Ca2+ regulation by the RyR2 channel.
- The precise mechanisms of redox-mediated RyR2 dysfunction in heart disease are not fully understood.
- This study investigates the role of SR-resident oxidoreductases in modulating RyR2 function under oxidative stress.
Purpose of the Study:
- To elucidate the role of endoplasmic reticulum oxidoreductase 1 alpha (Ero1α) in redox-mediated RyR2 channel dysfunction in cardiac hypertrophy.
- To identify the molecular interactions between Ero1α, RyR2, and associated proteins in regulating SR Ca2+ handling.
- To evaluate the therapeutic potential of targeting the Ero1α-ERp44-RyR2 axis for treating cardiac arrhythmias.
Main Methods:
- Utilized a rat model of cardiac hypertrophy induced by thoracic aortic banding (TAB).
- Employed ex vivo whole-heart optical mapping and Ca2+ and reactive oxygen species imaging in isolated ventricular myocytes (VMs).
- Investigated the effects of pharmacological (EN460) and genetic inhibition/overexpression of Ero1α, alongside site-directed mutagenesis and molecular dynamics simulations.
Main Results:
- Increased intra-SR oxidation and Ero1α expression were observed in TAB VMs, correlating with impaired Ca2+ handling.
- Ero1α inhibition normalized SR redox state, improved Ca2+ transient amplitude and SR Ca2+ content, and reduced spontaneous Ca2+ waves.
- Ero1α mediated RyR2 channel hyperactivation via dissociation of intraluminal protein ERp44, involving a redox-sensitive interaction at RyR2 cysteine 4806.
Conclusions:
- A novel intraluminal interaction axis involving RyR2, ERp44, and Ero1α was identified in cardiac hypertrophy.
- Inhibition of Ero1α stabilizes the RyR2-ERp44 complex, mitigating spontaneous Ca2+ release and Ca2+-dependent tachyarrhythmias.
- Targeting Ero1α represents a promising therapeutic strategy for hypertrophic hearts, improving SR Ca2+ regulation without inducing hypo-oxidative stress.
Background:
Oxidative stress in cardiac disease promotes proarrhythmic disturbances in Ca2+ homeostasis, impairing luminal Ca2+ regulation of the sarcoplasmic reticulum (SR) Ca2+ release channel, the RyR2 (ryanodine receptor), and increasing channel activity. However, exact mechanisms underlying redox-mediated increase of RyR2 function in cardiac disease remain elusive. We tested whether the oxidoreductase family of proteins that dynamically regulate the oxidative environment within the SR are involved in this process.
Methods:
A rat model of hypertrophy induced by thoracic aortic banding (TAB) was used for ex vivo whole heart optical mapping and for Ca2+ and reactive oxygen species imaging in isolated ventricular myocytes (VMs).
Results:
The SR-targeted reactive oxygen species biosensor ERroGFP showed increased intra-SR oxidation in TAB VMs that was associated with increased expression of Ero1α (endoplasmic reticulum oxidoreductase 1 alpha). Pharmacological (EN460) or genetic Ero1α inhibition normalized SR redox state, increased Ca2+ transient amplitude and SR Ca2+ content, and reduced proarrhythmic spontaneous Ca2+ waves in TAB VMs under β-adrenergic stimulation (isoproterenol). Ero1α overexpression in Sham VMs had opposite effects. Ero1α inhibition attenuated Ca2+-dependent ventricular tachyarrhythmias in TAB hearts challenged with isoproterenol. Experiments in TAB VMs and human embryonic kidney 293 cells expressing human RyR2 revealed that an Ero1α-mediated increase in SR Ca2+-channel activity involves dissociation of intraluminal protein ERp44 (endoplasmic reticulum protein 44) from the RyR2 complex. Site-directed mutagenesis and molecular dynamics simulations demonstrated a novel redox-sensitive association of ERp44 with RyR2 mediated by intraluminal cysteine 4806. ERp44-RyR2 association in TAB VMs was restored by Ero1α inhibition, but not by reducing agent dithiothreitol, as hypo-oxidation precludes formation of covalent bond between RyR2 and ERp44.
Conclusions:
A novel axis of intraluminal interaction between RyR2, ERp44, and Ero1α has been identified. Ero1α inhibition exhibits promising therapeutic potential by stabilizing RyR2-ERp44 complex, thereby reducing spontaneous Ca2+ release and Ca2+-dependent tachyarrhythmias in hypertrophic hearts, without causing hypo-oxidative stress in the SR.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Regulation of the Unfolded Protein Response
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Directing Proteins to the Rough Endoplasmic Reticulum
Rheumatic Heart Disease I: Introduction

